NASDAQ:MLTX
Recent Insider Activity Could Benefit MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $1.96 ...
Investing in MoonLake Immunotherapeutics (MLTX) Is Getting More Attractive
MoonLake Immunotherapeutics’s recently made public that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
MoonLake Immunotherapeutics (MLTX) may enjoy gains as insiders got busy in the recent days
MoonLake Immunotherapeutics’s recently made public that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
Recent Insider Activity Could Benefit MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
Investing in MoonLake Immunotherapeutics (MLTX) Is Getting More Attractive
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
MoonLake Immunotherapeutics’s latest rating changes from various analysts
In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
MLTX’s latest rating updates from top analysts.
MoonLake Immunotherapeutics’s recently made public that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
Analysts review MoonLake Immunotherapeutics’s rating
In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
